Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Comment by carduon Oct 22, 2011 8:51am
395 Views
Post# 19172767

RE: RE: Another zinger from Yahoo! _ Why Post It?

RE: RE: Another zinger from Yahoo! _ Why Post It?"Are you a fraudster or a masochist?"

I'm what you optimists call a pessimist, I'm a realist.

What precisely  is faulty in the Yahoo post? Has not the timelines been constantly overstated? Has not the Company been silent as to the progress of the trials? Has not BT been lackluster in his presentations. Remember he is the frontman for our company.

I remember, as JL, you encouraged people on this board to buy on margin at $6-7/share. You would not answer honest questions by posters that you had maligned. If there is a fraudster on this board I suggest you look in the nearest mirror to identify the culprit.

As for me, me and my twenty odd thousand shares will be in this to the end, which will end successfully IMO, despite the weak performance of management.
Bullboard Posts